WIL Research Partners with Three S Japan
Friday, May 24, 2013
Partnership to expand full portfolio of global safety assessment services to the Japanese market.

CytRx Announces Initial Results from PK Clinical Trial with Aldoxorubicin
Wednesday, May 22, 2013
Aldoxorubicin shows prolonged clinical activity in two clinical trial patients with small cell lung cancer who have failed other therapies.

RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
Wednesday, May 22, 2013
Talks come as part of the company’s push to carve out a share of the $142 billion U.S. drug delivery market.

Computer Models More Accurate than Animal Trials
Tuesday, May 21, 2013
Expert systems estimate drug uptake in humans (bioavailability) more precisely than animal experiments.

Hurel Corporation Makes New Appointment to Board
Tuesday, May 21, 2013
Leading pharmaceutical executive and toxicologist Dr. James S. MacDonald appointed to Board of Directors.

BioDuro Opens State-of-the-Art Discovery Lab in Shanghai
Friday, May 17, 2013
New facility offers customized portfolio of services to meet expanding client demand.

Halo Pharma Announces Investment and Formal Collaboration with Altus
Thursday, May 16, 2013
Halo Pharma has taken a minority ownership position in, and established a formal collaboration with, Altus Formulation Inc.

Certara and Veristat Expand Clinical Trial Service Offerings
Wednesday, May 15, 2013
Collaboration offers clients more streamlined and efficient approach to clinical trial planning.

<<	1 2 3 4 5 6 7	>>
Showing Results 1 - 10 of 2168